← Back to Patent Explorer
US5948639A Expired / Lapsed US ⏱️ 0.0 years remaining

TGF-β pathway genes

Assignee: Millennium Pharmaceuticals Inc
•
Filing: 1997-04-10
•
Granted: 1999-09-07
•
Expires: 2017-04-10
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract The invention provides isolated nucleic acids molecules, designated EMI1 nucleic acid molecules, which encode proteins involved in growth factor, e.g., TGF-β, cell signaling. The invention also provides antisense nucleic acid molecules, recombinant expression vectors containing EMI1 nucleic acid molecules, host cells into which the expression vectors have been introduced, and nonhuman transgenic animals in which an EMI1 gene has been introduced or disrupted. The invention still further provides isolated EMI1 proteins, fusion proteins, antigenic peptides and anti-EMI1 antibodies. Diagnostic, screening, and therapeutic methods utilizing compositions of the invention are also provided.

Inventors

  • 👤 Carlos J. Gimeno
  • 👤 Dean A. Falb

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 10:56
CPC Classifications
C; C07; C07K; C07K14/00; C07K14/435; C07K14/46; C07K14/47; C07K14/4701; C07K14/4702; C07K14/4703; A; A01; A01K; A01K2217/00; A01K2217/05; A61; A61K; A61K38/00

Claims Analysis

Total Claims: 28
Claim 1
Independent Claim 17 words
An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or the complement thereof.
Claim 2
Dependent Claim 17 words
An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:1 or the complement thereof.
Claim 3
Dependent Claim 17 words
An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:3 or the complement thereof.
Claim 4
Dependent Claim 17 words
An isolated nucleic acid molecule comprising the nucleotide sequence of SEQ ID NO:3 or the complement thereof.
Claim 5
Dependent Claim 27 words
An isolated nucleic acid molecule comprising the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC as Accession Number 98375 or the complement thereof.
Claim 6
Dependent Claim 27 words
An isolated nucleic acid molecule comprising the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC as Accession Number 98375 or the complement thereof.
Claim 7
Dependent Claim 21 words
An isolated nucleic acid molecule comprising the coding region of the nucleotide sequence of SEQ ID NO:1 or the complement thereof.
Claim 8
Dependent Claim 21 words
An isolated nucleic acid molecule comprising the coding region of the nucleotide sequence of SEQ ID NO:1 or the complement thereof.
Claim 9
Dependent Claim 18 words
An isolated nucleic acid molecule encoding the amino acid sequence of SEQ ID NO-2, or the complement thereof.
Claim 10
Dependent Claim 18 words
An isolated nucleic acid molecule encoding the amino acid sequence of SEQ ID NO-2, or the complement thereof.
Claim 11
Dependent Claim 16 words
An isolated nucleic acid molecule encoding a SEQ ID NO:2 fusion protein, or the complement thereof.
Claim 12
Dependent Claim 16 words
An isolated nucleic acid molecule encoding a SEQ ID NO:2 fusion protein, or the complement thereof.
Claim 13
Dependent Claim 22 words
An isolated nucleic acid molecule comprising a naturally-occurring allelic variant of the nucleotide sequence of SEQ ID NO:1, or the complement thereof.
Claim 14
Dependent Claim 22 words
An isolated nucleic acid molecule comprising a naturally-occurring allelic variant of the nucleotide sequence of SEQ ID NO:1, or the complement thereof.
Claim 15
Dependent Claim 21 words
A vector comprising the isolated nucleic acid molecule of any one of claims 1, 2, 3, 4, 5, 6, or 7.
Claim 16
Dependent Claim 11 words
The vector of claim 8, which is a recombinant expression vector.
Claim 17
Dependent Claim 11 words
A host cell containing the recombinant expression vector of claim 9.
Claim 18
Dependent Claim 9 words
A host cell containing the vector of claim 8.
Claim 19
Dependent Claim 32 words
A method for expressing a polypeptide, comprising transforming a host cell with the vector of claim 8, and culturing said host cell in a suitable medium such that said polypeptide is expressed.
Claim 20
Dependent Claim 17 words
The method of claim 12, further comprising isolating said polypeptide from the medium of the host cell.
Claim 21
Dependent Claim 18 words
An isolated nucleic acid molecule consisting of the nulcleotide sequence of SEQ ID NO:1, or the complement thereof.
Claim 22
Dependent Claim 18 words
An isolated nucleic acid molecule consisting of the nulcleotide sequence of SEQ ID NO:1, or the complement thereof.
Claim 23
Dependent Claim 18 words
An isolated nucleic acid molecule consisting of the nucleotide sequence of SEQ ID NO:3, or the complement thereof.
Claim 24
Dependent Claim 18 words
An isolated nucleic acid molecule consisting of the nucleotide sequence of SEQ ID NO:3, or the complement thereof.
Claim 25
Dependent Claim 28 words
An isolated nucleic acid molecule consisting of the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC as Accession Number 98375, or the complement thereof.
Claim 26
Dependent Claim 28 words
An isolated nucleic acid molecule consisting of the nucleotide sequence of the DNA insert of the plasmid deposited with ATCC as Accession Number 98375, or the complement thereof.
Claim 27
Dependent Claim 23 words
An isolated nucleic acid molecule consisting of a naturally-occurring allelic variant of the nucleotide sequence of SEQ ID NO:1, or the complement thereof.
Claim 28
Dependent Claim 23 words
An isolated nucleic acid molecule consisting of a naturally-occurring allelic variant of the nucleotide sequence of SEQ ID NO:1, or the complement thereof.

References Cited (Backward Citations)

No citation records indexed.

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 2002-09-06 2003-03-08 2003-09-07 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 2006-09-06 2007-03-08 2007-09-07 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2010-09-06 2011-03-08 2011-09-07 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag